Higher hospitalization and mortality rates among SARS-CoV-2-infected persons in rural America

被引:19
|
作者
Anzalone, Alfred Jerrod [1 ,2 ]
Horswell, Ronald [3 ,4 ]
Hendricks, Brian M. [5 ,6 ]
Chu, San [3 ,4 ]
Hillegass, William B. [7 ,8 ]
Beasley, William H. [9 ,10 ]
Harper, Jeremy R. [11 ]
Kimble, Wesley [5 ,6 ]
Rosen, Clifford J. [12 ,13 ]
Miele, Lucio [4 ,14 ]
McClay, James C. [1 ,2 ]
Santangelo, Susan L. [12 ,13 ,15 ]
Hodder, Sally L. [5 ,6 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
[2] Great Plains IDeA CTR, Omaha, NE USA
[3] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA
[4] LACaTS Ctr, Baton Rouge, LA USA
[5] West Virginia Univ, Morgantown, WV 26506 USA
[6] West Virginia Clin & Translat Sci Inst, Morgantown, WV USA
[7] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[8] Mississippi Ctr Clin & Translat Res, Jackson, MS USA
[9] Univ Oklahoma, Norman, OK 73019 USA
[10] Oklahoma Clin & Translat Sci Inst, Oklahoma City, OK USA
[11] Owl Hlth Works LLC, Indianapolis, IN USA
[12] Maine Med Ctr, Res Inst, Scarborough, ME USA
[13] Northern New England Clin St Translat Res Network, Burlington, VT USA
[14] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[15] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源
JOURNAL OF RURAL HEALTH | 2023年 / 39卷 / 01期
关键词
COVID-19; hospitalization; mortality; SARS-CoV-2; urban-rural health; URBAN DISPARITIES; CARE; OUTCOMES; LIFE;
D O I
10.1111/jrh.12689
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose Rural communities are among the most underserved and resource-scarce populations in the United States. However, there are limited data on COVID-19 outcomes in rural America. This study aims to compare hospitalization rates and inpatient mortality among SARS-CoV-2-infected persons stratified by residential rurality. Methods This retrospective cohort study from the National COVID Cohort Collaborative (N3C) assesses 1,033,229 patients from 44 US hospital systems diagnosed with SARS-CoV-2 infection between January 2020 and June 2021. Primary outcomes were hospitalization and all-cause inpatient mortality. Secondary outcomes were utilization of supplemental oxygen, invasive mechanical ventilation, vasopressor support, extracorporeal membrane oxygenation, and incidence of major adverse cardiovascular events or hospital readmission. The analytic approach estimates 90-day survival in hospitalized patients and associations between rurality, hospitalization, and inpatient adverse events while controlling for major risk factors using Kaplan-Meier survival estimates and mixed-effects logistic regression. Findings Of 1,033,229 diagnosed COVID-19 patients included, 186,882 required hospitalization. After adjusting for demographic differences and comorbidities, urban-adjacent and nonurban-adjacent rural dwellers with COVID-19 were more likely to be hospitalized (adjusted odds ratio [aOR] 1.18, 95% confidence interval [CI], 1.16-1.21 and aOR 1.29, CI 1.24-1.1.34) and to die or be transferred to hospice (aOR 1.36, CI 1.29-1.43 and 1.37, CI 1.26-1.50), respectively. All secondary outcomes were more likely among rural patients. Conclusions Hospitalization, inpatient mortality, and other adverse outcomes are higher among rural persons with COVID-19, even after adjusting for demographic differences and comorbidities. Further research is needed to understand the factors that drive health disparities in rural populations.
引用
收藏
页码:39 / 54
页数:16
相关论文
共 50 条
  • [21] Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
    Aid, Malika
    Busman-Sahay, Kathleen
    Vidal, Samuel J.
    Maliga, Zoltan
    Bondoc, Stephen
    Starke, Carly
    Terry, Margaret
    Jacobson, Connor A.
    Wrijil, Linda
    Ducat, Sarah
    Brook, Olga R.
    Miller, Andrew D.
    Porto, Maciel
    Pellegrini, Kathryn L.
    Pino, Maria
    Hoang, Timothy N.
    Chandrashekar, Abishek
    Patel, Shivani
    Stephenson, Kathryn
    Bosinger, Steven E.
    Andersen, Hanne
    Lewis, Mark G.
    Hecht, Jonathan L.
    Sorger, Peter K.
    Martinot, Amanda J.
    Estes, Jacob D.
    Barouch, Dan H.
    [J]. CELL, 2020, 183 (05) : 1354 - +
  • [22] ZBP1 inflames the SARS-CoV-2-infected lung
    Chaoran Yin
    Siddharth Balachandran
    [J]. Cell Research, 2023, 33 : 333 - 334
  • [23] A specific molecular signature in SARS-CoV-2-infected kidney biopsies
    Isnard, Pierre
    Vergnaud, Paul
    Garbay, Serge
    Jamme, Matthieu
    Eloudzeri, Maeva
    Karras, Alexandre
    Anglicheau, Dany
    Galantine, Valerie
    Eddine, Arwa Jalal
    Gosset, Clement
    Pourcine, Franck
    Zarhrate, Mohammed
    Gibier, Jean-Baptiste
    Rensen, Elena
    Pietropaoli, Stefano
    Barba-Spaeth, Giovanna
    Duong-Van-Huyen, Jean-Paul
    Molina, Thierry J.
    Mueller, Florian
    Zimmer, Christophe
    Pontoglio, Marco
    Terzi, Fabiola
    Rabant, Marion
    [J]. JCI INSIGHT, 2023, 8 (05)
  • [24] Reinfection or Relapse in SARS-CoV-2-Infected Patients; Does it Occur?
    Karimi, Abdollah
    Shirvani, Fariba
    Seifi, Kimia
    [J]. ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2020, 8 (03):
  • [25] Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
    Puhl, Ana C.
    Gomes, Giovanni F.
    Damasceno, Samara
    Fritch, Ethan J.
    Levi, James A.
    Johnson, Nicole J.
    Scholle, Frank
    Premkumar, Lakshmanane
    Hurst, Brett L.
    Lee-Montiel, Felipe
    Veras, Flavio P.
    Batah, Sabrina S.
    Fabro, Alexandre T.
    Moorman, Nathaniel J.
    Yount, Boyd L.
    Dickmander, Rebekah J.
    Baric, Ralph S.
    Pearce, Kenneth H.
    Cunha, Fernando Q.
    Alves-Filho, Jose C.
    Cunha, Thiago M.
    Ekins, Sean
    [J]. ACS OMEGA, 2022, 7 (36): : 31935 - 31944
  • [26] ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
    Posch, W.
    Vosper, J.
    Zaderer, V
    Noureen, A.
    Constant, S.
    Bellmann-Weiler, R.
    Lass-Floerl, C.
    Wilflingseder, D.
    [J]. MBIO, 2021, 12 (02):
  • [27] Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark
    Rasmussen, Line Dahlerup
    Lebech, Anne-Mette
    Ovrehus, Anne
    Poulsen, Birgitte Klindt
    Christensen, Hanne Rolighed
    Nielsen, Henrik
    Johansen, Isik Somuncu
    Omland, Lars Haukali
    Wiese, Lothar
    Helleberg, Marie
    Storgaard, Merete
    Dalager-Pedersen, Michael
    Rasmussen, Thomas A.
    Benfield, Thomas
    Petersen, Tonny Studsgaard
    Andersen, Ase Bengard
    Gram, Mie Agermose
    Stegger, Marc
    Edslev, Sofie Marie
    Obel, Niels
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (06) : 1820 - 1833
  • [28] Serum Ferritin and its Importance for SARS-CoV-2-Infected Patients
    Nasif, Wesam A.
    Mukhtar, Mohammed H.
    Althubiti, Mohammad A.
    Alamodi, Hiba S.
    Balkhir, Omar Y.
    Qurban, Yazeed K.
    Alhasni, Mohammad G.
    Alharbi, Ammar K.
    Alnemary, Sultan O.
    Fatani, Sameer H.
    [J]. CLINICAL LABORATORY, 2022, 68 (08) : 1543 - 1552
  • [29] Central nervous system complications in SARS-CoV-2-infected patients
    Zhonggui Li
    Danyu Lin
    Xiaoshuang Xu
    Xiaohuan Liu
    Jieli Zhang
    Kaixun Huang
    Feiyifan Wang
    Jianfeng Liu
    Zhi Zhang
    Enxiang Tao
    [J]. Journal of Neurology, 2023, 270 : 4617 - 4631
  • [30] Central nervous system complications in SARS-CoV-2-infected patients
    Li, Zhonggui
    Lin, Danyu
    Xu, Xiaoshuang
    Liu, Xiaohuan
    Zhang, Jieli
    Huang, Kaixun
    Wang, Feiyifan
    Liu, Jianfeng
    Zhang, Zhi
    Tao, Enxiang
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4617 - 4631